We are live on ! Find out more
PIPR icon

Piper Sandler

Positive
Neutral
Negative
Sentiment 3-Months
Positive 52.6%
Neutral 42.1%
Negative 5.3%

Positive
Zacks Investment Research
14 days ago
PIPR vs. MCO: Which Stock Is the Better Value Option?
Investors interested in stocks from the Financial - Miscellaneous Services sector have probably already heard of Piper Sandler Companies (PIPR) and Moody's (MCO). But which of these two companies is the best option for those looking for undervalued stocks?
PIPR vs. MCO: Which Stock Is the Better Value Option?
Neutral
Business Wire
16 days ago
Piper Sandler Expands Restructuring Group With the Addition of John D'Amico
NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John D'Amico as a managing director in the Piper Sandler restructuring group. D'Amico will be focused on advising a broad range of clients in complex restructurings and special situation transactions.With approximately 25 years of investment banking and corporate advisory experience, D'Amico has advised companies, boards of directors, official and ad hoc creditor com.
Piper Sandler Expands Restructuring Group With the Addition of John D'Amico
Positive
Zacks Investment Research
1 month ago
IX vs. PIPR: Which Stock Should Value Investors Buy Now?
Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Orix (IX) and Piper Sandler Companies (PIPR). But which of these two stocks is more attractive to value investors?
IX vs. PIPR: Which Stock Should Value Investors Buy Now?
Neutral
PRNewsWire
1 month ago
CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus
Financing led by Piper Sandler Merchant Banking, with participation from new investors Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic Participation by existing investors, including Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds Proceeds will support the conclusion of the STRIDE pivotal trial, continued operational scale-up, advancement of regulatory work toward a future Premarket Approval (PMA) submission to the FDA, and preparations for US commercialization Board strengthened with addition of Kevin Conroy as Lead Independent Director, Christopher Geyen as Chair of the Audit Committee, and Tom Schnettler representing Series C investors BOSTON, June 4, 2026 /PRNewswire/ -- CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, today announced it has successfully completed the initial closing of an $85 million Series C financing. Piper Sandler Merchant Banking led the financing with participation from Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic, along with existing investors Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds.
CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus
Neutral
Business Wire
1 month ago
Piper Sandler Appoints New Co-Heads of Services and Industrials Investment Banking and Enhances Focus on Private Equity Advisory Business
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, has named Rob Parker and Tripp Griffin as co-heads of services and industrials investment banking. Matt Sznewajs and John Tye, current co-heads of the services & industrials team, have been appointed vice chairmen of investment banking, and co-heads of private equity advisory. David Lee will join Sznewajs and Tye in leading the firm's private equity advisory effort while continuing to lead Piper S.
Piper Sandler Appoints New Co-Heads of Services and Industrials Investment Banking and Enhances Focus on Private Equity Advisory Business
Positive
MarketBeat
1 month ago
Record Revenue, Rising Dividends—So Why Aren't Analysts Saying Buy?
Piper Sandler NYSE: PIPR posted its best first quarter ever on May 7, with 33% revenue growth and record investment banking. It was the 10th consecutive quarter of year-over-year growth.
Record Revenue, Rising Dividends—So Why Aren't Analysts Saying Buy?
Neutral
Business Wire
2 months ago
Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group
NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distr.
Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group
Negative
24/7 Wall Street
2 months ago
Wall Street Splits on Uber: Goldman Sachs Cuts Price Target While Piper Sandler Hikes
Wall Street delivered a split verdict on Uber Technologies (NYSE:UBER | UBER Price Prediction) following the company's Q1 2026 earnings report on May 6.
Wall Street Splits on Uber: Goldman Sachs Cuts Price Target While Piper Sandler Hikes
Positive
Zacks Investment Research
2 months ago
5 Dividend Stocks to Watch as Markets Swing on Inflation Fears
FDS and peers lift dividends as volatile markets and inflation fears push investors toward steady income plays backed by solid fundamentals.
5 Dividend Stocks to Watch as Markets Swing on Inflation Fears
Neutral
Seeking Alpha
2 months ago
Piper Sandler Companies (PIPR) Q1 2026 Earnings Call Transcript
Piper Sandler Companies (PIPR) Q1 2026 Earnings Call Transcript
Piper Sandler Companies (PIPR) Q1 2026 Earnings Call Transcript